SGEN Seagen Inc

Price (delayed)

$185.78

Market cap

$33.5B

P/E Ratio

68.3

Dividend/share

N/A

EPS

$2.72

Enterprise value

$32.64B

Sector: Healthcare
Industry: Biotechnology

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington , is ...

Highlights

The company's revenue has surged by 133% YoY and by 84% QoQ
SGEN's gross profit has soared by 131% year-on-year and by 85% since the previous quarter
SGEN's debt is down by 6% year-on-year but it is up by 2.1% since the previous quarter
The quick ratio has decreased by 21% YoY and by 19% QoQ

Key stats

What are the main financial stats of SGEN
Market
Shares outstanding
180.31M
Market cap
$33.5B
Enterprise value
$32.64B
Valuations
Price to earnings (P/E)
68.3
Price to book (P/B)
14.32
Price to sales (P/S)
17.39
EV/EBIT
68.63
EV/EBITDA
61.31
EV/Sales
17.51
Earnings
Revenue
$1.86B
EBIT
$475.65M
EBITDA
$532.46M
Free cash flow
$570.68M
Per share
EPS
$2.72
Free cash flow per share
$3.27
Book value per share
$12.98
Revenue per share
$10.68
TBVPS
$13.99
Balance sheet
Total assets
$3B
Total liabilities
$746.93M
Debt
$65M
Equity
$2.26B
Working capital
$1.57B
Liquidity
Debt to equity
0.03
Current ratio
3.65
Quick ratio
3.39
Net debt/EBITDA
-1.6
Margins
EBITDA margin
28.6%
Gross margin
91%
Net margin
25.3%
Operating margin
21.1%
Efficiency
Return on assets
20%
Return on equity
24.5%
Return on invested capital
37.4%
Return on capital employed
19.7%
Return on sales
25.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SGEN stock price

How has the Seagen stock price performed over time
Intraday
-2.63%
1 week
5.64%
1 month
-6.1%
1 year
70.96%
YTD
6.08%
QTD
6.08%

Financial performance

How have Seagen's revenue and profit performed over time
Revenue
$1.86B
Gross profit
$1.7B
Operating income
$393.45M
Net income
$472.41M
Gross margin
91%
Net margin
25.3%
SGEN's net margin has surged by 167% year-on-year
The company's operating margin has surged by 164% QoQ and by 162% YoY
The company's revenue has surged by 133% YoY and by 84% QoQ
SGEN's gross profit has soared by 131% year-on-year and by 85% since the previous quarter

Growth

What is Seagen's growth rate over time

Valuation

What is Seagen stock price valuation
P/E
68.3
P/B
14.32
P/S
17.39
EV/EBIT
68.63
EV/EBITDA
61.31
EV/Sales
17.51
The price to book (P/B) is 38% more than the 5-year quarterly average of 10.4 and 8% more than the last 4 quarters average of 13.2
SGEN's equity is up by 27% YoY and by 24% from the previous quarter
The company's revenue has surged by 133% YoY and by 84% QoQ
The P/S is 22% below the last 4 quarters average of 22.2 and 3.4% below the 5-year quarterly average of 18.0

Efficiency

How efficient is Seagen business performance
The ROS has soared by 162% YoY

Dividends

What is SGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SGEN.

Financial health

How did Seagen financials performed over time
The company's total liabilities has surged by 135% YoY and by 113% QoQ
SGEN's total assets is up by 43% year-on-year and by 39% since the previous quarter
SGEN's debt is 97% smaller than its equity
SGEN's equity is up by 27% YoY and by 24% from the previous quarter
The debt to equity has decreased by 25% from the previous quarter and by 25% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.